[ ADVOCACY MATTERS ]
ADDRESSING
CANCER SURVIVORSHIP A cancer survivor is defined as anyone living with a history of cancer — from the moment of diagnosis through the remainder of life. Current data shows that 87 percent of people with Hodgkin lymphoma (HL) and over 72 percent of people with non-Hodgkin lymphoma (NHL) are still alive five years after their diagnosis. Better diagnostic tools and more effective treatments play a critical part in improved survival rates; however, the challenge now facing many survivors is how to achieve long-term quality of life after treatment has ended. Emily Tonorezos, MD, MPH, Director of the Office of Cancer Survivorship at the National Cancer Institute (NCI), in the Division of Cancer Control & Population Sciences, shares what she and the agency are doing to raise awareness of and address issues that cancer survivors may face, as well as future directions in cancer survivorship research.
PULSE | WINTER EDITION 2021
